Intuitive Surgical reported fourth-quarter earnings that topped analyst forecasts, sending shares up 1.3% in after-hours trading. The robotic surgery pioneer posted adjusted earnings per share of $2.53 against a $2.26 consensus estimate. Revenue reached $2.87 billion, a 19% increase from the prior year.

The strong performance was fueled by a 17% rise in da Vinci procedures and a 44% jump in Ion procedures. The company placed 532 da Vinci systems, up from 493 a year earlier, growing its installed base to 11,106 systems. CEO Gary Guthart cited strong reception for the newest da Vinci 5 model.

Looking ahead, Intuitive guided for 2026 worldwide da Vinci procedure growth of 13% to 15%, a slowdown from 18% in 2025. The company expects a non-GAAP gross margin of 67% to 68%, including a 1.2% tariff impact. It ended the quarter with $9.03 billion in cash and investments.